Source 1review2025MED
Toolkit/artificial intelligence-guided diagnostics
artificial intelligence-guided diagnostics
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Non-viral vectors, nanoparticle systems, and artificial intelligence-guided diagnostics are being explored to address these limitations and support personalized care.
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete computational method used to design, rank, or analyze an engineered system.
Mechanisms
No mechanism tags yet.
Techniques
Computational DesignTarget processes
diagnosticValidation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Non-viral vectors, nanoparticle systems, and artificial intelligence-guided diagnostics are being explored to address current limitations and support personalized care.
Non-viral vectors, nanoparticle systems, and artificial intelligence-guided diagnostics are being explored to address these limitations and support personalized care.
Key challenges for emerging RP therapies include delivery efficiency, immune responses, and treatment of large or dominant-negative mutations.
Challenges persist in delivery efficiency, immune responses, and treating large or dominant-negative mutations.
The review describes voretigene neparvovec approval for RPE65-associated RP as a milestone in gene therapy.
The approval of voretigene neparvovec for RPE65-associated RP marked a milestone in gene therapy
Ongoing trials targeting RPGR, USH2A, and CEP290 are expanding therapeutic options for retinitis pigmentosa.
ongoing trials targeting mutations in RPGR, USH2A, and CEP290 are expanding therapeutic options
Targeted treatments for retinitis pigmentosa include gene replacement therapy, RNA-based therapies, and CRISPR/Cas9 gene editing.
Advances in molecular genetics have led to the development of targeted treatments, including gene replacement therapy, RNA-based therapies, and CRISPR/Cas9 gene editing
Optogenetic therapy and stem cell transplantation are presented as additional strategies particularly for patients with advanced disease.
Optogenetic therapy and stem cell transplantation represent additional strategies, particularly for patients with advanced disease.
Approval Evidence
1 source1 linked approval claimfirst-pass slug artificial-intelligence-guided-diagnostics
Non-viral vectors, nanoparticle systems, and artificial intelligence-guided diagnostics are being explored to address these limitations and support personalized care.
Source:
emerging strategysupports
Non-viral vectors, nanoparticle systems, and artificial intelligence-guided diagnostics are being explored to address current limitations and support personalized care.
Non-viral vectors, nanoparticle systems, and artificial intelligence-guided diagnostics are being explored to address these limitations and support personalized care.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.